STEVEN W. KING

Corporate Board Profile

Tech Score: 0/100

Oncotelic Therapeutics, Inc.

Filing Date	Source Excerpt
2020-06-25	On March 9, 2020, the Company and Artius Bioconsulting, LLC (Artius), for which Mr. King is the Managing Member, entered into an amendment to the Consulting Agreement dated December 1, 2018... Mr. King also agreed to assist the Company with strategic advisory services... Mr. King will generally provide his services at a rate of $237 per hour... The Compensation Committee consists of Dr. Maida (Chair) and Mr. King. The Nominating and Governance Committee consists of Mr. King (Chair) and Dr. Maida.

Filing Date

Source Excerpt

2020-06-25

On March 9, 2020, the Company and Artius Bioconsulting, LLC (Artius), for which Mr. King is the Managing Member, entered into an amendment to the Consulting Agreement dated December 1, 2018... Mr. King also agreed to assist the Company with strategic advisory services... Mr. King will generally provide his services at a rate of $237 per hour... The Compensation Committee consists of Dr. Maida (Chair) and Mr. King. The Nominating and Governance Committee consists of Mr. King (Chair) and Dr. Maida.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22